INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

78,613 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
PK
Puylaert KevinChief Sales Officer
SOPHSOPHiA GENETICS SA
Open-market sale
SELL$14.13
3 sh
Mar 31, 2026Apr 1, 2026
Page 1242 of 1966
← PrevNext →
traded Mar 31, 2026
+1d
SEC Form 4

Evidence

31
DG
Doucette Veronica GSVP/Human Resources Officer
CIVBCIVISTA BANCSHARES, INC.
Grant or award
A—
908 sh
Mar 11, 2026Apr 1, 2026
traded Mar 11, 2026
+21dSEC Form 4

Evidence

29
HL
Heard Carlos LawrenceSenior Vice President & CFO
BFSSAUL CENTERS, INC.
Open-market purchase
BUY$10K
500 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

27
LC
Laden ChristopherChief Financial Officer
EYENational Vision Holdings, Inc.
Tax withholding
F$251K
9,702 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

27
LC
Longhito ChristopherFMR SVP & CSCO
GICGLOBAL INDUSTRIAL Co
Open-market sale
SELL$11K
364 sh
Mar 26, 2026Apr 1, 2026
traded Mar 26, 2026
+6dSEC Form 4

Evidence

27
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$5.02M
59.8K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

27
CB
Cree BrianPresident & Interim CEO
VTSVitesse Energy, Inc.
Open-market sale
SELL$1.31M
70.1K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

27
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.65M
19.5K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

26
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$291K
2,968 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

26
ZY
Zeng YanChief Financial Officer
ATHMAutohome Inc.
Open-market sale
SELL$12K
2,704 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

26
XB
Xiang BiboChief Technology Officer
ATHMAutohome Inc.
Open-market sale
SELL$5,314
1,240 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

26
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$1.85M
61.3K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

24
KA
Kohl Laura A.Director
WTFCWINTRUST FINANCIAL CORP
Grant or award
A$55K
395 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

24
RB
Read BrianChief Financial Officer
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$10K
1,263 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

24
CB
Cree BrianPresident & Interim CEO
VTSVitesse Energy, Inc.
Open-market sale
SELL$926K
50.0K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

24
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$619K
7,232 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

23
LC
Longhito ChristopherFMR SVP & CSCO
GICGLOBAL INDUSTRIAL Co
Open-market sale
SELL$995
32 sh
Mar 27, 2026Apr 1, 2026
traded Mar 27, 2026
+5dSEC Form 4

Evidence

23
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$247K
2,532 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

22
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$1.67M
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

22
LC
Longhito ChristopherFMR SVP & CSCO
GICGLOBAL INDUSTRIAL Co
Option exercise
M$85K
2,927 sh
Mar 27, 2026Apr 1, 2026
traded Mar 27, 2026
+5dSEC Form 4

Evidence

21
YT
Yaacobi TalDirector
VLNValens Semiconductor Ltd.
Open-market sale
SELL$1,554
1,400 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

21
SD
Safran DavidDirector
CMPCOMPASS MINERALS INTERNATIONAL INC
Grant or award
A—
1,071 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

21
NJ
Napolitano JanetDirector
FTNTFortinet, Inc.
Option exercise
M—
649 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

21
HC
Hargarten ChristinaCHIEF ACCOUNTING OFFICER
RHRH
Option exercise
M—
1,125 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

21
RH
Ramani HiteshChief Accounting Officer
PATHUiPath, Inc.
Grant or award
A—
123.5K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

21
LC
Laden ChristopherChief Financial Officer
EYENational Vision Holdings, Inc.
Option exercise
M—
26.1K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

20
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift
G—
6,291 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

20
NA
Nievaard Lisa AnnDirector
FINWFinwise Bancorp
Grant or award
A$50K
3,179 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

20
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.55M
1.00M sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

19
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.72M
21.8K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

19
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$196K
6,710 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

19
LC
Longhito ChristopherFMR SVP & CSCO
GICGLOBAL INDUSTRIAL Co
Option exercise
M$47K
1,984 sh
Mar 27, 2026Apr 1, 2026
traded Mar 27, 2026
+5dSEC Form 4

Evidence

19
LA
Lange Douglas A.VP - WATER TREATMENT GROUP
HWKNHAWKINS INC
Tax withholding
F$584K
3,855 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

19
GA
Gupta AshimCOO & CFO
PATHUiPath, Inc.
Tax withholding
F$545K
49.1K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

19
MJ
Mangine David J.VP-INDUSTRIAL SOLUTIONS GROUP
HWKNHAWKINS INC
Tax withholding
F$530K
3,493 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

19
EL
Emmons LanceEVP and CFO
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Tax withholding
F$313K
8,350 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

17
HC
Hargarten ChristinaCHIEF ACCOUNTING OFFICER
RHRH
Option exercise
M—
1,125 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

17
GA
Gupta AshimCOO & CFO
PATHUiPath, Inc.
Grant or award
A—
306.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

17
BM
Bang Jimmy MChief Lending Officer
OPBKOP Bancorp
Option exercise
M—
1,020 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

17
NJ
Napolitano JanetDirector
FTNTFortinet, Inc.
Option exercise
M—
649 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence